We found that siRNA-mediated knockdown of FBXL5 or BTG3 significantly restored the invasive abilities and reduced the anti-tumor activity of cisplatin in iASPP- or miR-20a-silenced CC cells (Fig. 4i and j; Additional file 1: Figure S1C). This evidence concerns the gene FBXL5 and neoplasm.